Insurance Health

Home Biosketch Publications

PATRICIA M. DANZON,

Ph.D.

Health Care Systems Department

The Wharton School

University of Pennsylvania

CURRICULUM VITAE

(double-click above to download Dr. Danzon's CV in .pdf format)

Office Address: Health Care Systems Department

The Wharton School

204 Colonial Penn Center

3641 Locust Walk

Philadelphia, PA 19104

Telephone: Office: 215-***-****

Fax: 215-***-****

Email ******@*******.*****.*******://hc.wharton.upenn.edu/danzon/index.htm

EDUCATION

Ph.D., University of Chicago, Economics, 1973

MA, University of Chicago, Economics, 1969

BA First Class, University of Oxford, England, Politics, Philosophy and Economics, 1968

ACADEMIC POSITIONS

Chair, Health Care Systems Department, 1994 1997, 2004 2007.

Celia Moh Professor, Health Care Systems Department; Joint appointment in Insurance and

Risk Management; The Wharton School, University of Pennsylvania, 1985 present

Visiting Professor, University of Chicago, Center for the Study of the Economy and the

State, 19881989

Associate Professor, Center for Health Policy and Institute of Policy Sciences

;

Adjunct

Professor, Department of Economics; Lecturer, Law School; Duke University, 19841985

Senior Research Fellow, Hoover Institution, Stanford University, 19801984

Research Economist, The Rand Corporation,

and

Instructor, Rand Graduate Institute for

Policy Studies19741980

Visiting Assistant Professor, Economics Department, University of California, San Diego,

1978

Lecturer, University of Chicago, 1972

SELECTED CONSULTING EXPERIENCE

Alliance of American Insurers

American Hospital Association

American Medical Association

Analysis Group, Inc.

Asian Development Bank

California Commission on Tort Reform

Committee for Economic Development

C-S First Boston

Florida Medical Association

Global Alliance for Vaccines (GAVI)

Health Insurance Association of America

Hospital Corporation of America

Institute for Civil Justice, The Rand Corporation

Insurance Services Office

Merck & Co. Inc.

New Zealand Business Roundtable

New Zealand Treasury

Pharmaceutical Research and Manufacturers Association

Pfizer, Inc.

U.S. AID

USHealthCare

World Bank

OTHER PROFESSIONAL ACTIVITIES

Journal of Risk and Insurance, 1990 1997

Law, Medicine and Health Care, 1984 1989

American Economic Review, 1982 1985

Other Professional Appointments

National Bureau of Economic Research, Research Associate, 2000 present.

Institute of Medicine, Member 1991 present.

National Academy of Social Insurance, Member, 1992 present.

National Academies, Policy & Global Affairs Oversight Board, Member, 2004 2010.

National Institutes of Health, Fogarty International Center Advisory Board, Member,

2004 2008.

GAVI, Economic Expert Group on Advance Market Commitment for Pneumococcal Vaccine,

2007 2008.

CGD, Drug Resistance Working Group, 2007 2008.

Institute of Medicine, Board on Global Health, Member, 2000 2004.

Institute of Medicine Committee on Malaria, Member, 2002 2004.

California Health Benefits Review Program, National Advisory Board, Member, 2004 2006.

American Enterprise Institute, Adjunct Scholar, 1993 2006.

European Commission, Working Party on Creating a Single Market in Pharmaceuticals,

1996 1998.

Association for Health Services Research, AHSR Fellow.

New Palgrave Dictionary of Economics and the Law, Advisory Board Member.

Australian National University, Centre for Law & Economics, Overseas Advisory Committee

Board.

American Law and Economics Association, Board Member, 1991 1993.

Economic Institute for Federal Judges, Faculty Member Program on Liability and Insurance,

George Mason Law School, 1990, 1991.

BIOSIS Board, 1999 2000.

Choral Arts Society of Philadelphia, 1999 2002.

Presbyterian Medical Center, Board, 1991 1993.

Selected Executive Education and Conference Organization

Wharton Windhover Program for Pharmaceutical Executives, Academic Co-Director, with Roger

Longman, The Aresty Institute, 1999 2011.

Novo Nordisk, 2011.

Sanofi, 2010.

Merck Vaccines, 2010.

Teva Program on Global Pharmaceuticals, July 2007. Academic Director

Wyeth/Pfizer Global Positioning, Nov. 2004 2010.

Merck, Finance 2004 2010.

Wharton Impact Conference on Pharmaceutical Innovation in the Global Economy. Conference

Organizer. The Wharton School, October 2002.

HONORS AND AWARDS

VISITING APPOINTMENTS AND FELLOWSHIPS

Visiting Fellow, London School of Economics and City University, Spring 1998

Visiting Fellow, Institute de Sciences Politiques, Paris, Summer 1992, 1993

Visiting Fellow, CS First Boston and Victoria University, New Zealand, Summer 1990

Visiting Fellow, Australian National University, Summer 1989

Mont Pelerin Society Fellowship 1982

Ford Foundation Fellowship University of Chicago 1968 1973

Fulbright Travel Grant 1968 1973

PUBLICATIONS

Books and Monographs

The Life Cycle of Pharmaceuticals: A Cross National Perspective. With Jeong Kim. Office

of Health Economics. March 2002.

Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison. With

LiWei Chao. London: Office of Health Economics. 2000.

Price Comparisons for Pharmaceuticals: A Review of US and Cross-National Studies. 1999.

Washington DC: AEI.

Reference Pricing:

Health Policy in 1984: The Crisis in Costs, in To Promote Prosperity: U.S. Domestic

Policy in the Mid1980s, ed. John Moore, Hoover Press, 1984.

Reimbursement Policies: Lessons from Medicare, in National Health Policy: What Role for

Government?, Hoover Press, 1982.

Theory of Solvency Regulation in the Property/Casualty Insurance Industry, with Dennis

Smallwood, in Studies in Regulation, ed. Gary Fromm, MIT Press, 1981.

A Dynamic Model of Optimum Bonus Management, in Defense Manpower Policy, ed. Richard V.

L. Cooper, The Rand Corporation, 1979.

Causes of the Medical Malpractice Insurance Crisis: Risk and Regulation, in The

Economics of Medical Malpractice, American Enterprise Institute, December, 1978.

Working Papers

Vaccine Supply: Effects of Regulation and Competition with Nuno S. Pereira. NBER

Working Paper 17205. July 2011.

Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven

Markets with Michael Furukawa. NBER Working Paper 17226. July 2011.

Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and

Procurement with Andrew Mulcahy and Adrian Towse. NBER Working Paper 17174 June 2011.

Value-based Differential Pricing: Setting Optimal Absolute and Relative Prices for Drugs

Cross-Nationally with Adrian Towse and Jorge Ferrandiz. December 2010.

Effects of Regulation on Drug Launch and Pricing in Interdependent Markets with Andrew

Epstein. NBER Working Paper NBER Working Paper No. 14041. Revised May 2009.

Differential Pricing of Pharmaceuticals: Reconciling Access, R&D and Patents. Report

for Working Group 2 of the WHO Commission on MacroEconomics and Health. Dec. 2001.

Defined Daily Doses for Pharmaceuticals: Risks and Potential. Health Care Systems

Department, The Wharton School. January 1996.

Can Cost Control and Innovation Co-Exist? OECD. September 1995.

The Effects of Price Regulation in the Pharmaceutical Industry. April 1995.

The Effects of Health Care Reform on Incentives for Innovation, with Li Wei Chao and

Allison Percy. February 1995.

Radical Alternatives for Medical Malpractice: Lessons from Sweden and New Zealand.

March 1993

The New Zealand Accident Compensation Scheme: Lessons for the U.S., Revised, March

1993.

Administrative Costs, Price Regulation and Efficiency: A New Look at Old Issues.

December 1992.

Gap and Supplementary Insurance in New Zealand: Theory, Evidence and Policy Options.

February 1992.

Medical Malpractice: Incidence and Incentive Effects, March 1990.

Mandated Employment-Based Health Insurance: Incidence and Efficiency Effects, Revised,

November 1989.

Other Published Reports

The Effects of Regulation on the Pharmaceutical Industry. Report to the Chaire

D Economie et Gestion de la Sante, Institut d Etudes Politiques de Paris. October 1994.

Pharmaceutical Price Regulation in New Zealand. Report to the New Zealand Department of

Health. 1991

Options for Health Care in New Zealand, 1990. Report to the New Zealand Business

Roundtable. CS-First Boston New Zealand Inc.

Covering the Uninsured: How Much Would It Cost? 1987. With Frank Sloan. LDI Policy

Decision Paper No. 9, December 1986.

State Health Insurance Pools: An Evaluation. Report to the Program on Access to Care,

North Carolina, August 1987.

Expanding EmploymentBased Health Insurance. Report to the Program on Access to Care,

North Carolina, August 1987.

An Evaluation of Solvency Regulation in the PropertyLiability Insurance Industry, with

Scott E. Harrington. Report to the Alliance of American Insurers, July 1986.

Alternative Financing of Health Care in Jamaica Report to the World Bank, October 1985.

Health Care for the Uninsured Poor, with C. Johnston Conover. Center for Health Policy

Research and Education, Duke University, August 1985.

The Resolution of Medical Malpractice Claims: Modelling the Bargaining Process, with

Lee A. Lillard, The Rand Corporation, R2792ICJ, 1982.

The Resolution of Medical Malpractice Claims: Research Results and Policy Implications,

with Lee A. Lillard, The Rand Corporation, R2793ICJ, 1982.

Economic Factors in the Use of Laboratory Tests of OfficeBased Physicians, The Rand

Corporation, R2525/1HCFA, 1982.

Civilian Earnings of Military Retirees, The Rand Corporation, R2355MRAL, 1981.

The Disposition of Medical Malpractice Claims, The Rand Corporation, R2622HCFA, 1980.

Why are Malpractice Premiums So High or So Low? The Rand Corporation, R2623HCFA, 1980.

Comments on NAIC Program to Monitor Competition in the PropertyLiability Insurance

Industry, NAIC Proceedings, Vol., No. 1, 1979.

Costs and Benefits of the Tort System if Viewed as a Compensation System, The Rand

Corporation, P5921, June 1977.

Professional Liability Insurance: The Case for Regulation, with Dennis Smallwood, The

Rand Corporation, WN9936CCCTR, May 1977.

Professional Liability, with Dennis Smallwood, California Citizens' Commission On Tort

Reform, 1976.

Projections of Military Retirement Costs: 19751993, The Rand Corporation, WN9064ARPA,

June 1975.

SELECTED TESTIMONY AND INVITED SPEECHES

Reference Pricing.

Reference Pricing.

OHE

SELECTED ACADEMIC CONFERENCE PRESENTATIONS

Conference in Celebration of George Stigler's 65th birthday, Chicago, January, 1976.

Discussant of paper by Victor R. Fuchs, The Irrational Pursuit of National Health

Insurance.

RESEARCH GRANTS RECEIVED (PI or Co-PI)

Year

Source

Purpose2008-2009Eli Lilly and Company

Fair Pricing of Pharmaceuticals

2002-2010Merck Co. Foundation

Pharmaceutical Policy, Economics and Management

2002-2008AHRQ

Advanced Training in Health Services Research (NRSA Institutional Training Program

(Support for Doctoral students)

2004-2006Merck & Co. and Pfizer, Inc. NBER.

International Price Comparisons for Pharmaceuticals

2003-2005

Ad Hoc Committee of the Pharmaceutical Industry. NBER.

Dynamic Competition in the Pharmaceutical Industry

2002-2005Yamanouchi USA Foundation

Research and Education on the Pharmaceutical and Biotechnology Industry

1990-2003AHCPR

Advanced Training in Health Services Research, NRSA Institutional Training Program

(Support for PhD students)

2002-2003Leonard Davis Institute

Models of Procurement for Vaccines

2000-2001

Huntsman Emerging Technologies Program

Determinants of R&D Success Biotech and Pharmaceuticals

2000-2001

Huntsman Emerging Technologies Program

Efficiency in the Market for Pharmaceutical-Biotech Deals

1999-2001Merck & Co. Inc.

International Price Comparisons for Pharmaceuticals

1994-1996Pfizer, Inc.

Competition & Regulation for Pharmaceuticals

1992-1994Pfizer, Inc

.

International Pharmaceutical Price Comparisons

1991-1992Robert Wood Johnson Foundation

No-Fault Insurance Systems for Medical Malpractice

1991

University Research Council

Pricing of Pharmaceuticals

1989-1990NAIC

Price Reductions and Cycles in the Property Liability Insurance Industry

1989-1990National Association of Insurance Commissioners

Capital Flows and Underwriting Cycles

1988-1990Hartford Foundation

Development of a Community Hospital Quality Index

1986-1990Robert Wood Johnson Foundation

Alternative Liability Regimes for Medical Malpractice

1987-1988

UPS Grant Program

Demand for Health Insurance

1983-1986

Program on Access to Care

Evaluation of Options for The Uninsured

1975

California Commission on Tort Reform

Professional Liability

1975-1978Health Care Financing AdministrationAnalysis of the Malpractice Crisis

1974-1976

Health Care Financing Administration

Reimbursement of Physicians and Hospitals for Lab Tests

Contact this candidate